Home/ Supplements/ Niacin/ NITRIX 2.0

NITRIX 2.0

product on market Tablet or Pill BSN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The product contains niacin and a proprietary blend designed to support nitric oxide production. Research on these components generally shows moderate evidence for enhancing blood flow and athletic performance. However, the overall evidence coverage for this specific formulation is very limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for NITRIX 2.0
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
5 Calorie(s)
Total Carbohydrates
1 Gram(s) (1% DV)
12 mg (75% DV)
Within RDA (0.9× RDA) 196 studies (A:5, B:63)
NITRIX 2.0 Proprietary Blend
3.6 Gram(s)

Other Ingredients

Stearic Acid Microcrystalline Cellulose Hydroxypropyl Methylcellulose Magnesium Stearate Croscarmellose Sodium Polydextrose Silicon Dioxide Hydroxypropyl Cellulose Red 40 Yellow 6 Titanium Dioxide Blue 2
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 3 tablets 2 times per day.

Warnings & Precautions

Warning: Consult your physician before using this product if you are taking any medications or are under a physician's care for a medical condition. Not for use by those under the age of 18, women that are pregnant, trying to get pregnant, or nursing, or those that are sensitive to niacin.

Not for use by those under the age of 18, women that are pregnant, trying to get pregnant, or nursing, or those that are sensitive to niacin. Keep out of reach of children.

Formulation Notes

NITRIX 2.0 supports workout performance, endurance, pumps and recovery with 3 grams of the amino acid L-citrulline, a precursor to nitric oxide, and 3g of creatine when taken as directed.

Pteropure & Resvida

3g Creatine per day 3g L-Citrulline per day

Additional Information

Store in a dry place away from direct sunlight.

This product has been manufactured by a Good Manufacturing Practices (GMP) facility.

V.3.518.0318US 6046154

Pumps Recovery Performance

Concentrated nitric oxide precursor

Made in the USA

This product contains ingredients of international and domestic origin

Metadata

Product Details

UPC / SKU8 34266 00518 5
DSLD Entry Date2019-02-25
Product TypeOther Combinations
FormTablet or Pill
BrandBSN
DSLD ID184099
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.